Front Row: Tumor/Radiosurgery

image

Take a front row seat as the experts share valuable and relevant information in this series on tumor and radiosurgery. 

Registrants can submit cases to be addressed during live discussions and gain insight on complex and nuanced cases. The Front Row Series includes the following webinars:

Schedule

May 3, 2021
6 pm CT
An Update on LITT for Deep Seated Tumors Michael Ivan, MD, FAANS
State of Immunotherapy for GBM Michael Lim, MD, FAANS
May 17, 7 pm CT Radiosurgery for Brain Metastases A Game Changer for Neurosurgeons and Oncologists L. Dade Lunsford, MD, FAANS
Radiosurgery for Arteriovenous Malformations and Trigeminal Neuralgia Jason Sheehan, MD, PhD, FAANS
May 24, 5 pm CT Minimally Invasive Parafascicular Surgery for Deep-Seated Brain Tumors Kaisorn Chaichana, MD, FAANS
5-ALA Fluorescence-Guided Surgery for High-Grade Gliomas Constantinos Hadjipanayis, MD, PhD, FAANS

Pricing

AANS Member$99
Non-member$179


Attendees will be able to submit cases and questions prior to the webinar by sending a message to epm@aans.org. These questions will be answered live during the webinar. 

The recordings will be available to those who purchase the live event.

CME Credits

The AANS designates this other activity ( live internet activity and enduring material) for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the Standard of Care for High-Grade Gliomas and Limitations of Surgical Resection
  • Explain 5-ALA Fluorescence-Guided Surgery
  • Describe Traditional Surgical Approaches to Subcortical Brain Tumors
  • Identify MIPS for Deep-Seated High Grade Gliomas

L. Dade Lunsford, MD

Lars Leksell Professor and Distinguished Professor Director Neurological Surgery Center for Image-Guided Neurosurgery Residency Training Program

University of Pittsburgh Medical Center

Jason Sheehan, MD, PhD

Departments of Neurological Surgery and Radiation Oncology

University of Virginia

Kaisorn Chaichana, MD, FACS, FAANS

Associate Professor of Neurosurgery Vice Chair of Education Neurosurgery Residency Program Director Director of Brain Tumor Surgery Director of Skull Base and Minimally Invasive Cranial Surgery

Mayo Clinic

Constantinos (Costas) G. Hadjipanayis, M.D., Ph.D.

Professor of Neurosurgery and Oncological Sciences Chair of Neurosurgery, Mount Sinai Union Square/Beth Israel Director of Neurosurgical Oncology, Mount Sinai Health System Director, Brain Tumor Nanotechnology Laboratory, Tisch Cancer Institute

Icahn School of Medicine at Mount Sinai

Georgios Zenonos, MD

Assistant Professor Neurological Surgery

UPMC

The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

Name

Company/Relationship

 

Michael Ivan, MD

Medtronic

Grants/Research Support

 

NX development

Consultant Fees

 

Magicleap

Grants/Research Support

Michael Lim, MD

Arbor, BMS, Accuray, Tocagen, Biohaven, Kyrin-Kyowa, Biohaven

Grants/Research Support

 

Tocagen, VBI, InCephalo Therapeutics, Pyramid Bio, Merck, BMS, Insightec, Biohaven, Sanianoia, Hemispherian, Black Diamond Therapeutics

Consultant Fees

 

Egret Therapeutics

Board, Trustee, Officer, Leadership position that could affect an entities' finances

Dale Lunsford, MD

Elekta

Stock Shareholder (purchased direct, i.e. not through Mutual Fund, retirement package, etc.)

 

Insightec DSMB

Consultant Fees

 

International Radiosurgery Research Foundation

Board, Trustee, Officer, Leadership position specifically with a neurosurgical or medical-related associated, non-profit or similar entity

 

Teladoc

Expert Medical Opinion Services Income

Constantinos G. Hadjipanayis, MD, PhD, FAANS

Synaptive Inc.

Consultant Fees

              

NX Development Corp

Consultant Fees

 

Stryker

Other Financial Support

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AANS designates this other activity ( live internet activity and enduring material) for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

.



Key:

Complete
Failed
Available
Locked
On- Demand : An update on LITT for deep seated tumors S and state of Immunotherapy for GBM
Open to view video.
Open to view video. Dr. Michael Ivan Dr. Michael Lim
Radiosurgery for Brain Metastases​ A Game Changer for Neurosurgeons and Oncologists​ and Radiosurgery for Arteriovenous Malformations and Trigeminal Neuralgia
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. L. Dade Lunsford, MD Jason Sheehan, MD, PhD
Minimally Invasive Parafascicular Surgery ​for Deep-Seated Brain Tumors and 5-ALA Fluorescence-Guided Surgery for High-Grade Gliomas
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Minimally Invasive Parafascicular Surgery ​for Deep-Seated Brain Tumors and 5-ALA Fluorescence-Guided Surgery for High-Grade Gliomas
CME Evaluation
Evaluation
10 Questions
Certificate -Front Row Series: Radiosurgery for Brain Metastases​ A Game Changer for Neurosurgeons and Oncologists​ AND Radiosurgery for Arteriovenous Malformations and Trigeminal Neuralgia
1.00 AMA PRA Category 1 CreditsTM credit  |  Certificate available
1.00 AMA PRA Category 1 CreditsTM credit  |  Certificate available
Certificate Front Row Series: An Update on LITT for Deep Seated Tumors AND State of Immunotherapy for GBM
1.00 AMA PRA Category 1 CreditsTM credit  |  Certificate available
1.00 AMA PRA Category 1 CreditsTM credit  |  Certificate available
Certificate -Minimally Invasive Parafascicular Surgery ​for Deep-Seated Brain Tumors and 5-ALA Fluorescence-Guided Surgery for High-Grade Gliomas
1.00 AMA PRA Category 1 CreditsTM credit  |  Certificate available
1.00 AMA PRA Category 1 CreditsTM credit  |  Certificate available